WHO Immunization Implementation Guide
0.2.0 - ci-build

WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/ and changes regularly. See the Directory of published versions

PlanDefinition: IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening

Official URL: http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTDengueNoScreen Version: 0.2.0
Draft as of 2025-09-17 Computable Name: IMMZD2DTDengueNoScreen

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening CYD-TDV (Dengvaxia), 3-dose schedule without pre-vaccination screening [when pre-vaccination screening is not feasible and in areas with recent documentation of seroprevalence rates of at least 80% by age 9 years]

Id: IMMZD2DTDengueNoScreen
Url: IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening
Version: 0.2.0
Title: IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening
Status: draft
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2025-09-17 23:03:28+0000
Publisher: WHO
Description:

IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening CYD-TDV (Dengvaxia), 3-dose schedule without pre-vaccination screening [when pre-vaccination screening is not feasible and in areas with recent documentation of seroprevalence rates of at least 80% by age 9 years]
Knowledge Capability: computable
Related Artifacts:

References

  • ​

    WHO recommendations for routine immunization - summary tables (January 2025)
Libraries:
IMMZD2DTDengueNoScreenLogic
Actions:
Determine if the client is due for Dengue.: Determine if the client is due for Dengue vaccine according to the national immunization protocol. CYD-TDV (Dengvaxia), 3-dose schedule without pre-vaccination screening [when pre-vaccination screening is not feasible and in areas with recent documentation of seroprevalence rates of at least 80% by age 9 years]
If: Applicability: Client is due for dengue vaccination (Client is due for dengue vaccination)
Then: Definition: IMMZ.D2.DT.Dengue.MR
Dynamic Values:
status: ('draft')
intent: ('proposal')
Check for Guidance for the patient regarding IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening.: Show Guidance for the patient regarding IMMZ.D2.DT.Dengue.3 doses without pre-vaccination screening.
If: Applicability: Has Guidance (Has Guidance)
Then: Definition: IMMZ.D2.DT.CR
Dynamic Values:
status: ('active')
payload.contentString: (Guidance)
category.coding: (Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' })
priority: (Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' })